AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: RNA
Report Date: 2026-09-08
Full Report: https://amaly.io/stock/RNA

EXECUTIVE SUMMARY
------------------
Compliance Status: COMPLIANT
Quality Rating: AA
Description: Avidity Biosciences, Inc. (RNA), a biotechnology company developing innovative therapies for rare neuromuscular diseases, exhibits strong alignment with Shariah principles. Its core business promotes the preservation of life through ethical medical research, with no involvement in prohibited activities. Financial ratios significantly outperform industry benchmarks and all major thresholds, indicating robust compliance. While not included in all indices due to its small-cap status, inclusion in key Shariah indices confirms overall acceptability. Investors may proceed with minimal purification requirements.

Purification Requirement: 0.45%
Index Inclusion: Included in MSCI Islamic Indices and FTSE Shariah Indices; Not included in S&P Dow Jones Shariah Indices and DJIM

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 0.0%
Liquidity Ratio: 25.5%
Interest Income Ratio: 0.0%
Purification Required: 0.45%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: INCLUDED
MSCI Islamic: INCLUDED
DJIM: INCLUDED
FTSE Shariah: INCLUDED
Total: 4 of 4
Last Verified: 2025-12-31

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q4 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-27T10:00:00Z

---
Full interactive report: https://amaly.io/stock/RNA
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.